Sabin's Statement on COVID-19 Vaccine Equity
Below is part of Sabin's statement on COVID-19 vaccine equity, released on April 22, 2021. Read the full statement.
The SARS-CoV-2 virus has disrupted the lives and livelihoods of people everywhere in the world. But for some, the toll has been far greater than for others.
Preexisting health inequities have been exposed and exacerbated by the COVID-19 pandemic. To account forpast injustices and ensure that their effects do not persist, every effort must be made to ensure that local, national and global responses to COVID-19 have equity at the core of their design.
Through an unprecedented global effort, the scientific, philanthropic, private and public sectors have partnered in innovative ways to develop and produce diagnostic tools, treatments and vaccines in record time. However, the potential effects of these immense accomplishments are blunted if these interventions are not rapidly distributed and widely deployed to all those in need. Over a year into the pandemic, many of the tools necessary to combat COVID-19 remain concentrated among the wealthiest nations and groups, while low- and middle-income countries (LMICs) and other vulnerable populations still struggle to find access...